Yi Chang
Direktor/Vorstandsmitglied bei NONGFU SPRING CO., LTD.
Aktive Positionen von Yi Chang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NONGFU SPRING CO., LTD. | Direktor/Vorstandsmitglied | 06.03.2020 | - |
Independent Dir/Board Member | 06.03.2020 | - | |
COWEALTH MEDICAL CHINA CO.,LTD. | Direktor/Vorstandsmitglied | 22.03.2019 | - |
Independent Dir/Board Member | 22.03.2019 | - | |
China Institute of Internal Audit | Corporate Officer/Principal | - | - |
Asian Development Bank China | Corporate Officer/Principal | - | - |
Shanghai Advanced Institute of Finance | Corporate Officer/Principal | 01.07.2018 | - |
Grant Thornton LLP (China) | Corporate Officer/Principal | - | - |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | Direktor/Vorstandsmitglied | 19.01.2021 | - |
Independent Dir/Board Member | 19.01.2021 | - |
Karriereverlauf von Yi Chang
Ehemalige bekannte Positionen von Yi Chang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SIPAI HEALTH TECHNOLOGY CO., LTD. | Direktor/Vorstandsmitglied | 30.07.2021 | 21.05.2024 |
Independent Dir/Board Member | 30.07.2021 | 21.05.2024 | |
LAKESHORE BIOPHARMA CO., LTD | Direktor/Vorstandsmitglied | - | 09.12.2023 |
Independent Dir/Board Member | - | 09.12.2023 | |
░░░░░░░░ ░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░ ░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░ ░░░░░ ░░ ░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░ ░░░░ ░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
Ausbildung von Yi Chang
University of Missouri | Graduate Degree |
Texas Tech University | Doctorate Degree |
National Taiwan University | Undergraduate Degree |
Statistik
International
China | 11 |
Vereinigte Staaten | 4 |
Taiwan | 2 |
Operativ
Corporate Officer/Principal | 7 |
Director/Board Member | 5 |
Independent Dir/Board Member | 5 |
Sektoral
Consumer Services | 5 |
Health Technology | 4 |
Consumer Non-Durables | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
NONGFU SPRING CO., LTD. | Consumer Non-Durables |
SIPAI HEALTH TECHNOLOGY CO., LTD. | Retail Trade |
COWEALTH MEDICAL CHINA CO.,LTD. | Health Technology |
LAKESHORE BIOPHARMA CO., LTD | Health Technology |
Private Unternehmen | 7 |
---|---|
Texas State Board of Public Accountancy | |
China Institute of Internal Audit | |
Ernst & Young (China) | |
Marcum Asia CPAs LLP
Marcum Asia CPAs LLP Miscellaneous Commercial ServicesCommercial Services Part of Marcum Wealth LLC, Marcum Asia CPAs LLP provides public accounting services. The company is based in Beijing, China. The CEO of the Chinese company is Enze Liang. | Commercial Services |
Asian Development Bank China | Government |
Grant Thornton LLP (China) | |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | Health Technology |